Lannett Company, Inc. (39)
Browse by Contract Category
Contracts
-
Certificate of Amendment to the Certificate of Incorporation of Lannett Company, Inc
(Filed With SEC on February 7, 2023)
-
Form of Retention Award Letter
(Filed With SEC on August 25, 2022)
-
Manufacture and Supply Agreement by and between Chartwell Pharmaceuticals Carmel, LLC, Chartwell Pharmaceuticals LLC, and Lannett Company, Inc
(Filed With SEC on May 10, 2022)
-
Asset Purchase Agreement by and between Chartwell Carmel Assets, LLC, Chartwell Pharmaceuticals LLC, Silarx Pharmaceuticals, Inc., Lannett Company, Inc., and Lannett Holdings, Inc
(Filed With SEC on May 10, 2022)
-
Amendment No. 1 to License and Supply Agreement between Recro Gainesville LLC (as successor to Alkermes Pharma Ireland Limited) and Kremers Urban Pharmaceuticals, Inc
(Filed With SEC on February 4, 2021)
-
Sublicense Agreement between Lannett Company, Inc. and Ypsomed AG
(Filed With SEC on February 2, 2023)
-
Contract of Sale-Office, Commercial and Multi-Family Residential Premises between Silarx Pharmaceuticals, Inc. and Chartwell Carmel Realty, LLC
(Filed With SEC on May 10, 2022)
-
Fourth Amendment to Restated Employment Agreement of John Kozlowski
(Filed With SEC on January 20, 2022)
-
Fourth Addendum to Employment Agreement of Timothy Crew
(Filed With SEC on January 20, 2022)
-
Third Addendum to Employment Agreement of Maureen Cavanaugh
(Filed With SEC on January 20, 2022)
-
Third Addendum to Employment Agreement of Samuel H. Israel
(Filed With SEC on January 20, 2022)
-
Third Addendum to Employment Agreement of John Abt
(Filed With SEC on January 20, 2022)
-
Amendment No. 1 to Distribution Agreement Between Respirent Pharmaceuticals Co. Ltd. and Lannett Company, Inc
(Filed With SEC on August 26, 2021)
-
Distribution Agreement Between Respirent Pharmaceuticals Co. Ltd. and Lannett Company, Inc
(Filed With SEC on August 26, 2021)
-
Supply Agreement by and among Lannett Company, Inc. and Sunshine Lake Pharma Co., Ltd
(Filed With SEC on May 6, 2021)
-
Collaboration and License Agreement by and among Lannett Company, Inc. and Sunshine Lake Pharma Co., Ltd
(Filed With SEC on May 6, 2021)
-
Amended and Restated Exchange Agreement dated April 8, 2021, among Lannett Company, Inc. and the participating lenders party thereto
(Filed With SEC on April 12, 2021)
-
Exchange Agreement dated April 5, 2021, among Lannett Company, Inc. and the participating lenders party thereto
(Filed With SEC on April 6, 2021)
-
Amendment No. 2 to License and Supply Agreement between Recro Gainesville LLC (as successor to Alkermes Pharma Ireland Limited) and Kremers Urban Pharmaceuticals, Inc
(Filed With SEC on February 4, 2021)
-
License and Supply Agreement with Alkermes Pharma Ireland Limited and Kremers Urban Pharmaceuticals Inc
(Filed With SEC on February 4, 2021)
-
Fourth Addendum to Employment Agreement of Timothy C. Crew dated December 28, 2020
(Filed With SEC on December 29, 2020)
-
Second Addendum to Amended and Restated Employment Agreement of Robert Ehlinger
(Filed With SEC on August 28, 2020)
-
Second Addendum to Employment Agreement of John Abt
(Filed With SEC on August 28, 2020)
-
Second Addendum to Employment Agreement of Samuel H. Israel
(Filed With SEC on August 28, 2020)
-
Second Addendum to Employment Agreement of Maureen Cavanaugh
(Filed With SEC on August 28, 2020)
-
Third Amendment to Restated Employment Agreement of John Kozlowski
(Filed With SEC on August 28, 2020)
-
Third Addendum to Employment Agreement of Timothy Crew
(Filed With SEC on August 28, 2020)
-
Amendment to Sinotherapeutics Distribution and Supply Agreement
(Filed With SEC on August 27, 2020)
-
Supply Agreement by and among North & South Brother Pharmacy Investment Co., Ltd, HEC GROUP PTY LTD and Lannett Company, Inc., dated as of November 21, 2019
(Filed With SEC on February 6, 2020)
-
Collaboration and License Agreement by and among Lannett Company, Inc., North & South Brother Pharmacy Investment Co., Ltd and HEC GROUP PTY LTD, dated as of November 21, 2019
(Filed With SEC on February 6, 2020)
-
Lannett Company, Inc. Non-Qualified Deferred Compensation Plan
(Filed With SEC on November 7, 2019)
-
Sinotherapeutics Distribution and Supply Agreement
(Filed With SEC on November 7, 2019)
-
Cediprof Agreement
(Filed With SEC on November 7, 2019)
-
Indenture, dated as of September 27, 2019, between the Company and Wilmington Trust, National Association, as trustee (including form of 4.50% Convertible Senior Notes due 2026)
(Filed With SEC on September 27, 2019)
-
Form of Capped Call Confirmations
(Filed With SEC on September 27, 2019)
-
Description of Capital Stock of Lannett Company, Inc
(Filed With SEC on August 28, 2019)
-
Second Amendment to Restated Employment Agreement of John Kozlowski, dated as of July 31, 2019
(Filed With SEC on August 1, 2019)
-
Separation Agreement and General Release by and between Martin Galvan and Lannett Company, Inc. dated May 22, 2019
(Filed With SEC on May 24, 2019)
-
Amneal Distribution and Transition Support Agreement
(Filed With SEC on February 7, 2019)